title: The same glucocorticoid in brand-name products. Does increasing the concentration result in greater topical biologic activity?
abstract: Many topical corticosteroid formulations are available as different concentrations of the steroid in a similar vehicle. We tested the existing assumption that higher concentrations give greater biologic activity. The vasoconstriction assay was used because of its known correlation with clinical activity. Statistical analyses of the different concentrations are as follows: Kenalog creams: 0.025% is equal to 0.1% is equal to 0.5%; Aristocort creams: 0.025% is equal to 0.1% is equal to 0.5%; Aristocort ointments: 0.1% is equal to 0.5%; Aristocort creams: 0.5% is equal to 0.025% but is less than 0.1%; Hytone cream: 1.0% is equal to 2.5%; Synalar creams: 0.01% is less than 0.025% which is less than 0.2%; Topicort creams: 0.25% is equal 0.05%; and Vallisone creams: 0.1% is greater than 0.01%. The assumption that increased concentration of the same steroid in the same vehicle type will give increased biologic activity is usually, but not always, incorrect for brand-name formulations now available.
authors.affiliation: Department of Medicine, University of California at San Diego, La Jolla 92093.
authors.forename: R B
authors.initials: RB
authors.lastname: Stoughton
authors.forename: K
authors.initials: K
authors.lastname: Wullich
mesh_terms: D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics; D001682:Biological Availability; D004305:Dose-Response Relationship, Drug; D004339:Drug Compounding; D005938:Glucocorticoids; D006801:Humans; D014677:Pharmaceutical Vehicles; D014661:Vasoconstriction / Q000187:drug effects
chemical_list: D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D014677:Pharmaceutical Vehicles